Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Age of Wonders 4 Sells over 250,000 Copies in Four Days

New and Veteran Players Alike Dive into Triumph’s Signature SeriesSTOCKHOLM and DELFT, Netherlands — May 9, 2023 — Paradox Interactive, a developer and publisher of truly magical experiences, today announced that Age of Wonders 4, the latest entry in the cherished fantasy strategy game series from Triumph Studios, has sold over 250,000 copies since its launch on May 2, 2023. Including pre-orders, these sales reflect total copies of both the standard and premium edition of the game across all platforms where it is available, including PC, PlayStation®5, and Xbox Series X and S consoles. Age

Internationally-renowned creative schools in new partnership

Berghs School of Communication and Miami Ad School, two of the world's top-ranked creative schools, are excited to announce their brand new partnership. The schools share a common focus on communication and advertising and boast strong industry relations. Through this partnership, students can now take a two-year portfolio program spanning Sweden and the US, combining an education from two of the best advertising schools in the world. – Berghs School of Communication and Miami Ad School are a very good brand match. We share a similar approach to creative education. It’s practical,

Corem signs another lease contract in New York

Corem has signed another lease contract for approximately 605 sq.m. of office space at the project property 1245 Broadway in New York. The tenant, a finance and technology company, will move in during the first quarter of 2024 and the lease term is 5 years.1245 Broadway, a 23-story office building located at the corner of 31st Street and Broadway in Manhattan, is Corem’s largest ongoing project and is being developed in collaboration with GDS Development Management (GDSNY). 1245 Broadway was designed by Skidmore, Owings & Merrill and features architectural cast-in-place concrete, a

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna Plc        Managers’ transactions     9 May 2023 at 4:00 p.m. Pihlajalinna Plc: Managers’ transactions The management's transaction notification is related to the transfer of Pihlajalinna Plc's own shares as part of the annual remuneration of the members of the Board of Directors, of which the company announced on 9 May 2023.  Person subject to the notification requirementName: Tiina KurkiPosition: Member of the Board/Deputy member Issuer: Pihlajalinna Oyj LEI: 74370058MTRLEDOCHV67 Notification type: INITIAL NOTIFICATION Reference number: 31169/4/4__

Kojamo enters into a new EUR 425 million credit agreement

Kojamo plc Press Release, 9 May 2023 at 4:00 p.m. EESTKojamo enters into a EUR 425 million credit agreement Kojamo plc has signed a new EUR 425 million credit facility agreement linked to its sustainability targets together with six relationship banks. The loan is secured and has a maturity of three years with two one-year extension options. The loan will be used for the refinancing of company’s existing indebtedness as well as for the group’s general financing needs. The margin of the credit facility is linked to Kojamo’s key sustainability targets related to the energy efficiency of

NinaData Partners with PubMatic to Deliver new Cookieless Advertising Solutions for Publishers and Brands

The solution integrates NinaData’s intent-based audience segments with PubMatic’s Connect Platform enabling media buyers to better reach in-market consumers with privacy-safe, personalised advertising messages.Finnish buying intent data platform NinaData  today announced a new partnership with PubMatic, an independent technology company delivering digital advertising’s supply chain of the future. Media buyers now have access to NinaData's advanced contextual targeting and buying intent data directly within PubMatic’s Connect platform. This integration powers more

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna Plc        Managers’ transactions     9 May 2023 at 3:55 p.m. Pihlajalinna Plc: Managers’ transactions The management's transaction notification is related to the transfer of Pihlajalinna Plc's own shares as part of the annual remuneration of the members of the Board of Directors, of which the company announced on 9 May 2023.  Person subject to the notification requirementName: Kim IgnatiusPosition: Member of the Board/Deputy member Issuer: Pihlajalinna Oyj LEI: 74370058MTRLEDOCHV67 Notification type: INITIAL NOTIFICATION Reference number: 31175/4/4_

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna Plc        Managers’ transactions     9 May 2023 at 3:50 p.m. Pihlajalinna Plc: Managers’ transactions The management's transaction notification is related to the transfer of Pihlajalinna Plc's own shares as part of the annual remuneration of the members of the Board of Directors, of which the company announced on 9 May 2023.  Person subject to the notification requirementName: Heli IisakkaPosition: Member of the Board/Deputy member Issuer: Pihlajalinna Oyj LEI: 74370058MTRLEDOCHV67 Notification type: INITIAL NOTIFICATION Reference number: 31178/4/4_

Correction EQL Pharma signs a license agreement with a large pharmaceutical company in Türkiye for Mellozzan (melatonin)

Previous press release is corrected due to a misstatement about local requirements in Türkiye. EQL has entered into an exclusive license agreement with a large pharmaceutical company for its product Mellozzan (melatonin) for Türkiye and Kazakhstan. "EQL has previously signed license agreements with parties for a number of countries, but this is a milestone as it is our first agreement with the sale of one of our products outside the borders of Europe," says Axel Schörling, CEO at EQL Pharma.Mellozzan contains the sleep hormone melatonin and is indicated for children who have ADHD and

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna Plc        Managers’ transactions     9 May 2023 at 3:45 p.m. Pihlajalinna Plc: Managers’ transactions The management's transaction notification is related to the transfer of Pihlajalinna Plc's own shares as part of the annual remuneration of the members of the Board of Directors, of which the company announced on 9 May 2023.  Person subject to the notification requirementName: Hannu JuvonenPosition: Member of the Board/Deputy member Issuer: Pihlajalinna Oyj LEI: 74370058MTRLEDOCHV67 Notification type: INITIAL NOTIFICATION Reference number: 31168/4/4

ASETEK - Mandatory Notification of Trade – New Chairman Acquires Shares

9 May 2023 – Newly elected Chairman of the Board of Directors and primary insider of Asetek A/S, René Svendsen-Tune, has on 8 May 2023 purchased 155,487 shares in the open market at an average price of NOK 3.87 per share. Following the transaction, René Svendsen-Tune owns 155,487 Asetek shares. About Asetek Asetek (ASTK.OL), a global leader in mechatronic innovation, is a Danish garage-to-stock-exchange success story. Founded in 2000, Asetek established its innovative position as the leading OEM developer and producer of the all-in-one liquid cooler for all major PC & Enthusiast gaming

Scandinavian ChemoTech - Updates from our animal care unit

Dr Omar Maher, an internationally renowned equestrian veterinarian, at the Atlantic Equine Services in Florida, performed his first TSE (Tumour Specific Electroporation™) treatment which targeted a large sarcoid on the hind leg. The TSE treatment was done under standing sedation, and we have already received a report that the sarcoid has completely fallen off.Another clinic in Florida has placed their first order of treatment kits. This small animal clinic is specialising in pet cancer and is led by a board-certified veterinary oncologist with over 10 years’ experience in the field. The

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna Plc        Managers’ transactions     9 May 2023 at 3:40 p.m. Pihlajalinna Plc: Managers’ transactions The management's transaction notification is related to the transfer of Pihlajalinna Plc's own shares as part of the annual remuneration of the members of the Board of Directors, of which the company announced on 9 May 2023.  Person subject to the notification requirementName: Seija TurunenPosition: Member of the Board/Deputy member Issuer: Pihlajalinna Oyj LEI: 74370058MTRLEDOCHV67 Notification type: INITIAL NOTIFICATION Reference number: 31166/5/4

Gurgl hosts FIS World Cup races for the first time

Gurgl will start the new winter season in November 2023 with a unique sporting highlight. Slalom stars like Lucas Braathen, Henrik Kristoffersen and Linus Straßer gather for the first time at the Diamond of the Alps for the start of the Slalom World Cup. The destination of Ötztal wants to enter the club of annual venues in the racing calendar thanks to perfect organization.In autumn 2023, Ötztal will become the center of alpine ski racing twice within a few weeks. At the end of October, the FIS Alpine World Cup traditionally celebrates its season kick-off with two giant slalom events held

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna Plc        Managers’ transactions     9 May 2023 at 3:35 p.m. Pihlajalinna Plc: Managers’ transactions The management's transaction notification is related to the transfer of Pihlajalinna Plc's own shares as part of the annual remuneration of the members of the Board of Directors, of which the company announced on 9 May 2023.  Person subject to the notification requirementName: Leena NiemistöPosition: Member of the Board/Deputy member Issuer: Pihlajalinna Oyj LEI: 74370058MTRLEDOCHV67 Notification type: INITIAL NOTIFICATION Reference number: 31163/4/4

ASETEK - Outcome of Annual General Meeting

- Following the general meeting, the Board of Directors constituted itself with Mr. René Svendsen-Tune as chairman and Mr. Erik Damsgaard as vice chairman.Aalborg, May 9, 2023 - Asetek A/S (OSE: ASTK) today held the annual general meeting at its offices in Aalborg, Denmark. The general meeting took note of the report by the Board of Directors and Management, and the audited annual report for 2022 was approved. The Nomination Committee reported on its activities during last year. The Nomination Committee’s proposed remuneration to be paid to the members of the Board of Directors were

CS MEDICA A/S exhibits at the leading event Vitafoods Europe with suppliers and experts from over 100 countries today

New opportunities abound at fairs. By participating in key events, CANNORDIC, subsidiary of CS MEDICA A/S, expects to expand its awareness and customer base. Today CANNORDIC welcomes guests at its booth at Vitafoods Europe for the nutraceutical industry at Palexpo, Geneva.CANNORDIC a/s, subsidiary of CS MEDICA A/S, is opening its booth O260 today, with 15.000 other industry experts from over 130 countries gathering to network, collaborate and show innovation at the world's nutraceutical event Vitafoods Europe. After the success last year when CANNORDIC launched its first-mover

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna Plc        Managers’ transactions     9 May 2023 at 3:30 p.m. Pihlajalinna Plc: Managers’ transactions The managers' transaction notification is related to the transfer of Pihlajalinna Plc's own shares as part of the annual remuneration of the members of the Board of Directors, of which the company announced on 9 May 2023.  Person subject to the notification requirementName: Jukka LeinonenPosition: Member of the Board/Deputy member Issuer: Pihlajalinna Oyj LEI: 74370058MTRLEDOCHV67 Notification type: INITIAL NOTIFICATION Reference number: 31160/4/4__

Irisity recruits new CFO

Irisity recruits new CFO.   Anna Anderström has at her own request decided to leave her role as CFO and COO of Irisity, taking on new challenges. Recruitment of a new CFO has been initiated; Anna will continue in her CFO and COO role until September 2023.   "Anna has done a good job during her short time in the company, we wish her continued success", says Keven Marier, CEO of Irisity     For further information: Keven Marier, Irisity CEO E-mail: keven.marier@irisity.com   This information is information that Irisity AB (publ) is obliged to make public

Bittium Corporation - Managers’ Transactions - Johan Westermarck

Bittium CorporationManagers’ Transactions Bittium Corporation - Managers’ Transactions - Johan Westermarck Bittium Corporation, Stock Exchange Release, May 9, 2023, at 3:00 pm (CEST+1) Person subject to the notification requirement Name: Johan Westermarck Position: Chief Executive Officer Issuer: Bittium Oyj LEI: 743700NFG5W5I59OVX65 Notification type: INITIAL NOTIFICATION Reference number: 31138/5/6 Transaction date: 2023-05-04 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009007264 Nature of transaction: ACQUISITION (X)

FIMEA renews Nanoform’s GMP license and Nanoform starts clinical API manufacturing of a blockbuster medicine candidate

Press release Nanoform Finland Plc May 9, 2023 15.00 Finnish time / 14.00 Swedish time FIMEA renews Nanoform’s GMP license and Nanoform starts clinical API manufacturing of a blockbuster medicine candidate Helsinki, Finland – Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, are delighted to announce that FIMEA (Finnish Medicines Agency) has completed another successful general good manufacturing practices (GMP) inspection of Nanoform. During the inspection on March 28[th], 2023, FIMEA fully reviewed Nanoform for compliance with its processes and

Cyxone receives patent approval from the US for the salt forms of the compound rabeximod

Cyxone (publ), a biotech company in autoimmune diseases, is pleased to announce that the company has obtained granted status for the US patent application 17/891,462 entitled Rabeximod Compounds from the United States Patent and Trademark Office (USPTO).The application covers the protection of salt forms of the compound rabeximod which is being developed as treatment for moderate to severe rheumatoid arthritis. The patent will be valid until 2042. ”We are delighted to receive the final approval for this important patent. It is an essential fundament for the future development and

ASSMANN is all about “NEW WORK NOW” at the Clerkenwell Design Week in London

Office furniture manufacturer presents contemporary workspaces and furnishing solutions for the New Work megatrend at international design festival in LondonAt the Clerkenwell Design Week in London, ASSMANN Office Furniture Ltd. will be presenting its diverse product portfolio for the comprehensive furnishing of innovative working environments and holistic room concepts, inviting visitors to come to its showroom on Turnmill Street from 23 to 25 May 2023. On display will be beautifully designed furniture and inspiring room concepts with a focus on FLEXIBLE OFFICE solutions and the New Work

Coor completes acquisition of Skaraborgs Städ

On the 4th of April, Coor announced that it had signed an agreement regarding the acquisition of Skaraborgs Städ. The acquisition has been approved by the Competition Authority. The transaction has been completed as of 9 May 2023.“The acquisition of Skaraborgs Städ increases our geographical coverage, and the company is a close fit with Coor’s growth strategy”, commented AnnaCarin Grandin, CEO and President of Coor. Please find more information, images etc. at www.coor.com or contact: AnnaCarin Grandin, President and CEO, Coor +46 10 559 57 70 annacarin.grandin@coor.com

There are no items matching the current filter
There are no more items matching the current filter
Back to top